1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:AVM flow characteristics (in terms of transit times) and the concentration of n-BCAa used with or without aneurysm coils
n-BCAa 0.5 Secs 0.75 Secs 0.83 Secs 1 Sec 50/50 with coils 0 0 0 0 50/50 0 2 0 0 60/40 with coils 4 6 0 1 60/40 0 4 0 1 65/35 with coils 1 1 0 1 65/35 1 3 0 0 70/30 with coils 1 1 0 0 70/30 1 1 1 2 Coils only 0 1 0 0
a Percentage of iodized oil (Lipiodol) over the percentage of n-BCA with or without coils.